MEDP - Medpace Holdings - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58506Q1094

Clinical Research, Drug Development, Medical Device Services

Medpace Holdings, Inc. is a leading provider of clinical research-based services for the development of drugs and medical devices. With operations in North America, Europe, and Asia, the company supports the entire clinical development process, from Phase I to Phase IV, across various therapeutic areas.

Their comprehensive suite of services includes development plan design, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance, and new drug application submissions. Additionally, they offer post-marketing clinical support services to ensure the success of their clients' products.

In addition to these services, Medpace Holdings, Inc. also provides specialized services, such as bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. This comprehensive range of services enables pharmaceutical, biotechnology, and medical device companies to navigate the complex process of bringing new products to market.

Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace Holdings, Inc. has established itself as a trusted partner for companies seeking to develop innovative treatments and devices. With a strong track record of delivering high-quality services, the company continues to support the development of life-changing products that improve human health.

For more information about Medpace Holdings, Inc. and its services, please visit their website at https://www.medpace.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for MEDP - Medpace Holdings  - Stock Price & Dividends

MEDP Stock Overview

Market Cap in USD 13,726m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2016-08-11

MEDP Stock Ratings

Growth 5y 89.3
Fundamental 84.0
Dividend 0.00
Rel. Performance vs Sector 2.93
Analysts 4.20/5
Fair Price Momentum 519.36 USD
Fair Price DCF 344.14 USD

MEDP Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

MEDP Growth Ratios

Growth 12m 71.77%
Growth Correlation 12m 70%
Growth Correlation 3m 52%
CAGR 5y 46.34%
CAGR/Mean DD 5y 4.17
Sharpe Ratio 12m 1.75
Alpha vs SP500 12m 41.69
Beta vs SP500 5y weekly 1.39
ValueRay RSI 45.22
Volatility GJR Garch 1y 43.13%
Price / SMA 50 4.09%
Price / SMA 200 21.99%
Current Volume 195.1k
Average Volume 20d 223.4k

External Links for MEDP Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of MEDP stocks?
As of July 21, 2024, the stock is trading at USD 421.31 with a total of 195,131 shares traded.
Over the past week, the price has changed by -4.90%, over one month by +5.16%, over three months by +13.26% and over the past year by +70.61%.
What are the forecast for MEDP stock price target?
According to ValueRays Forecast Model, MEDP Medpace Holdings will be worth about 583 in July 2025. The stock is currently trading at 421.31. This means that the stock has a potential upside of +38.39%.
Issuer Forecast Upside
Wallstreet Target Price 447.3 6.17
Analysts Target Price 269.5 -36.0
ValueRay Target Price 583 38.4